104 related articles for article (PubMed ID: 11377401)
21. No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?
Visani G; Isidori A; Grafone T; Tosi P; Santini V; Malagola M; Martinelli G; Piccaluga PP; Gaziev D; Ottaviani E; Sparaventi G; Tura S
Leuk Lymphoma; 2004 Jul; 45(7):1361-4. PubMed ID: 15359633
[TBL] [Abstract][Full Text] [Related]
22. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
Bierau J; Van Gennip AH; Leen R; Helleman J; Caron HN; Van Kuilenburg AB
Int J Cancer; 2003 Jan; 103(3):387-92. PubMed ID: 12471622
[TBL] [Abstract][Full Text] [Related]
23. The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease.
Best OG; Che Y; Singh N; Forsyth C; Christopherson RI; Mulligan SP
Leuk Lymphoma; 2012 Jul; 53(7):1367-75. PubMed ID: 22149137
[TBL] [Abstract][Full Text] [Related]
24. Effects of cytosine arabinoside and hydroxyurea on the synthesis of deoxyribonucleotides and DNA replication in L1210 cells.
Matsumoto M; Rey DA; Cory JG
Adv Enzyme Regul; 1990; 30():47-59. PubMed ID: 2403036
[TBL] [Abstract][Full Text] [Related]
25. Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells.
Fernandes DJ; Smith-Nanni C; Paff MT; Neff TA
Cancer Res; 1988 Apr; 48(7):1850-5. PubMed ID: 3349463
[TBL] [Abstract][Full Text] [Related]
26. Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.
Yamamoto S; Yamauchi T; Kawai Y; Takemura H; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Int J Hematol; 2007 Feb; 85(2):108-15. PubMed ID: 17321987
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine inhibits DNA replication: a rationale for its use in the treatment of acute leukemias.
Gandhi V; Huang P; Plunkett W
Leuk Lymphoma; 1994; 14 Suppl 2():3-9. PubMed ID: 7881348
[TBL] [Abstract][Full Text] [Related]
28. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
Abdel-Aziz W; Jiang HY; Hickey RJ; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):312-9. PubMed ID: 10755320
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors.
Hunáková L; Suliková M; Duraj J; Sedlák J; Chorváth B
Neoplasma; 1996; 43(5):291-5. PubMed ID: 8996546
[TBL] [Abstract][Full Text] [Related]
30. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine.
Mirzayans R; Enns L; Cubitt S; Karimian K; Radatus B; Paterson MC
Biochim Biophys Acta; 1994 Oct; 1227(1-2):92-100. PubMed ID: 7918688
[TBL] [Abstract][Full Text] [Related]
31. Single-strand breaks in DNA by 1-beta-D-arabinofuranosylcytosine and enhanced resistance frequency to N-phosphonoacetyl-L-aspartate.
Chen Y; Goz B
Anticancer Res; 1991; 11(1):301-4. PubMed ID: 1850218
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of cytosine arabinoside in Tetrahymena pyriformis.
Benhura MA
Comp Biochem Physiol B; 1985; 80(4):821-5. PubMed ID: 3922672
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside.
Geller HM; Cheng KY; Goldsmith NK; Romero AA; Zhang AL; Morris EJ; Grandison L
J Neurochem; 2001 Jul; 78(2):265-75. PubMed ID: 11461962
[TBL] [Abstract][Full Text] [Related]
34. Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas.
Pan BF; Nelson JA
Cancer Chemother Pharmacol; 2007 Apr; 59(5):697-702. PubMed ID: 17009030
[TBL] [Abstract][Full Text] [Related]
35. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
[TBL] [Abstract][Full Text] [Related]
36. Activation of deoxycytidine kinase by various nucleoside analogues.
Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
[TBL] [Abstract][Full Text] [Related]
37. Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells.
Avramis VI; Nandy P; Kwock R; Solorzano MM; Mukherjee SK; Danenberg P; Cohen LJ
Anticancer Res; 1998; 18(4A):2327-38. PubMed ID: 9703875
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of action of fludarabine nucleoside against human Raji lymphoma cells.
Christopherson RI; Mactier S; Almazi JG; Kohnke PL; Best OG; Mulligan SP
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):375-83. PubMed ID: 24940695
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation.
Sreenivasan Y; Sarkar A; Manna SK
Oncogene; 2003 Jul; 22(28):4356-69. PubMed ID: 12853972
[TBL] [Abstract][Full Text] [Related]
40. Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance.
Cheong JW; Kim Y; Eom JI; Jeung HK; Min YH
Mol Med Rep; 2016 Apr; 13(4):3433-40. PubMed ID: 26935591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
